An update of pemetrexed (P) plus gemcitabine (G) as front-line chemotherapy for patients (pts) with malignant pleural mesothelioma (MPM): A phase II clinical trial
Janne P, Simon G, Langer C, Taub R, Dowlati A, Fidias P, Bloss L, Ye Z, Obasaju C, Kindler H
An update of pemetrexed (P) plus gemcitabine (G) as front-line chemotherapy for patients (pts) with malignant pleural mesothelioma (MPM): A phase II clinical trial